Apellis Pharmaceuticals, Inc. · NASDAQ:APLS

EcoR1 Capital, LLC's stake in Apellis Pharmaceuticals, Inc. fell to 2.70% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

EcoR1 Capital, LLC's stake in Apellis Pharmaceuticals, Inc. fell to 2.70%, 3,447,156 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
2.70%
Shares
3,447,156
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
EcoR1 Capital, LLC2.70%3,447,156
Oleg Nodelman2.70%3,447,156
EcoR1 Capital Fund Qualified, L.P.2.50%3,219,256

Source

View original at SEC

Related